Subscribe to RSS

DOI: 10.1055/a-2566-3952
Early Enoxaparin Treatment in a Newborn with Cerebral Venous Sinus Thrombosis and Acute Cerebellar Hemorrhage

Abstract
Objective
To evaluate the management of anticoagulant therapy in neonates with cerebral sinus venous thrombosis (CSVT), focusing on potential benefits and risks.
Study Design
We report the case of a full-term neonate diagnosed with CSVT, highlighting the rationale for early anticoagulation with unfractionated heparin. A brief literature review supports our clinical decision-making, considering current evidence and expert consensus despite limited neonatal-specific guidelines.
Results
Heparin therapy was started shortly after diagnosis, without hemorrhagic complications. Neuroimaging showed complete thrombus resolution. The neonate had a normal neurological examination at discharge. Follow-up confirmed overall good clinical condition and showed mild axial hypotonia and convergent strabismus suggestive of cortical visual impairment.
Conclusion
Management of CSVT in neonates remains debated. While heparin may carry a risk of bleeding, delaying treatment can lead to thrombus progression. Our case supports the potential safety and efficacy of early heparin use in selected patients. Tailored, risk-based decisions may improve outcomes, though further studies are needed to establish standardized protocols.
Keywords
neonatal intracranial hemorrhage - neonatal cerebral thrombosis - anticoagulant therapy - cerebral sinus venous thrombosis - treatment timingPublication History
Received: 08 November 2023
Accepted: 18 December 2024
Accepted Manuscript online:
26 March 2025
Article published online:
21 April 2025
© 2025. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/)
Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA
-
References
- 1 Martinelli I, Bucciarelli P, Passamonti SM, Battaglioli T, Previtali E, Mannucci PM. Long-term evaluation of the risk of recurrence after cerebral sinus-venous thrombosis. Circulation 2010; 121 (25) 2740-2746
- 2 Fitzgerald KC, Williams LS, Garg BP, Carvalho KS, Golomb MR. Cerebral sinovenous thrombosis in the neonate. Arch Neurol 2006; 63 (03) 405-409
- 3 Bhatt MD, Chan AK. Venous thrombosis in neonates. Fac Rev 2021; 10: 20
- 4 Kouzmitcheva E, Moharir M. Neonatal cerebral sinovenous thrombosis: the anticoagulation debate. Dev Med Child Neurol 2018; 60 (09) 853
- 5 Rossor T, Arichi T, Bhate S, Hart AR, Raman Singh R. Anticoagulation in the management of neonatal cerebral sinovenous thrombosis: a systematic review and meta-analysis. Dev Med Child Neurol 2018; 60 (09) 884-891
- 6 Roach ES, Golomb MR, Adams R. et al; American Heart Association Stroke Council, Council on Cardiovascular Disease in the Young. Management of stroke in infants and children: a scientific statement from a Special Writing Group of the American Heart Association Stroke Council and the Council on Cardiovascular Disease in the Young. Stroke 2008; 39 (09) 2644-2691
- 7 Monagle P, Chan AKC, Goldenberg NA. et al. Antithrombotic therapy in neonates and children: antithrombotic therapy and prevention of thrombosis, 9th: American College of Chest Physicians evidence-based clinical practice guidelines. Chest 2014; 146 (06) 1694
- 8 Chalmers E, Ganesen V, Liesner R. et al; British Committee for Standards in Haematology. Guideline on the investigation, management and prevention of venous thrombosis in children. Br J Haematol 2011; 154 (02) 196-207
- 9 Yang JY, Chan AK, Callen DJ, Paes BA. Neonatal cerebral sinovenous thrombosis: sifting the evidence for a diagnostic plan and treatment strategy. Pediatrics 2010; 126 (03) e693-e700
- 10 Berfelo FJ, Kersbergen KJ, van Ommen CH. et al. Neonatal cerebral sinovenous thrombosis from symptom to outcome. Stroke 2010; 41 (07) 1382-1388
- 11 Moharir MD, Shroff M, Stephens D. et al. Anticoagulants in pediatric cerebral sinovenous thrombosis: a safety and outcome study. Ann Neurol 2010; 67 (05) 590-599
- 12 Ramenghi LA, Cardiello V, Rossi A. Neonatal cerebral sinovenous thrombosis. Handb Clin Neurol 2019; 162: 267-280
- 13 Moharir MD, Shroff M, Pontigon AM. et al. A prospective outcome study of neonatal cerebral sinovenous thrombosis. J Child Neurol 2011; 26 (09) 1137-1144
- 14 Lebas A, Chabrier S, Fluss J. et al; French Society for Paediatric Neurology, European Paediatric Neurology Society. EPNS/SFNP guideline on the anticoagulant treatment of cerebral sinovenous thrombosis in children and neonates. Eur J Paediatr Neurol 2012; 16 (03) 219-228